Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Single-Payer Healthcare
  • Federal Workers’ Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

WHAT'S NEW

  • Single-Payer Healthcare
  • Federal Workers' Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Apr 14 2026

Full Issue

Viewpoints: Age Limits Shouldn't Block Access To Breakthrough Drugs; Good Riddance To Illegal NIH Funding Cuts

Editorial writers discuss these public health issues.

Stat: Age-Based Approvals For Rare Diseases Can Be Devastating 

For most of my life, my family has been advocating for therapies to help my twin brother. While the recent approval of a new drug should give us reason to celebrate, there is still more work to do. (Nathan Grant, 4/14)

The Washington Post: DOGE Funding Cuts For NIH Research Grants Are Officially Dead 

The Trump administration quietly conceded defeat last week on its misguided push to slash research funding from the National Institutes of Health. That’s a relief to researchers, but all Americans benefit from the basic and applied research that would have been disrupted by permanent cuts. (4/13)

The Boston Globe: Mass. Must Eliminate Nonmedical Vaccine Exemptions

Amid a dangerous upswing in vaccine disinformation, exacerbated by the anti-vaccine rhetoric of US Health and Human Services secretary Robert F. Kennedy Jr., parents are increasingly turning to nonmedical exemptions to avoid vaccinating their children. (John Snyder, 4/12)

Bloomberg: The UK Has A Dentist Problem, But It's Not About Private Care

When you’ve got a bad toothache and there’s no immediate relief available, you need something to take your mind off the pain. The Competition and Markets Authority’s study into the supply of private dental services in the UK has the look of a distraction. (Matthew Brooker, 4/14)

The Washington Post: Kennedy’s Raw Milk Movement Is Dangerous, But Don’t Overreact 

Last month, Utah passed a law to increase the amount of raw milk producers can sell and ease testing requirements. Legislatures in Iowa, Oklahoma and Michigan are considering similar bills to expand access to these products. (Leana S. Wen, 4/14)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF